The U.S. Food and Drug Administration has declared a shortage of Eli Lilly’s Mounjaro, the latest diabetes drug to be in short supply.
Due to increased demand for the medication, pharmacies may experience delays in receiving full shipments of the 5-milligram dose through January, according to a posting this week on the regulator’s website.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
